Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV
Status:
Completed
Trial end date:
2020-10-23
Target enrollment:
Participant gender:
Summary
Double-Blind, Randomised, Placebo-Controlled Exploratory Study to Estimate the Prophylactic
Efficacy of Palivizumab in Healthy Adult Participants Inoculated with Respiratory Syncytial
Virus (RSV).